T2 Biosystems Announces Reverse Stock Split Effective Today
12 oct. 2023 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Reports Granting of Inducement Award
06 oct. 2023 16h07 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 06, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to...
T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023
05 oct. 2023 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel
19 sept. 2023 09h00 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Reports Granting of Inducement Award
15 sept. 2023 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards...
T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase
07 sept. 2023 16h05 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Praises CDC’s Actions Aimed at Optimizing U.S. Hospital Sepsis Programs
28 août 2023 08h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Aug. 28, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today praised...
T2 Biosystems Regains Compliance with Nasdaq’s Market Value of Listed Securities Requirement
09 août 2023 08h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Announces Second Quarter 2023 Financial Results
07 août 2023 16h05 HE
|
T2 Biosystems, Inc.
Received FDA Breakthrough Device Designation for Candida auris test, achieved record quarterly sepsis test panel orders and received second largest sepsis driven T2Dx® Instrument order LEXINGTON,...
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirements
31 juil. 2023 08h30 HE
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...